The Athletics Integrity Unit (AIU) has banned the 2017 world cross country bronze medalist Lilian Kasait for 10 months (from 19 April 2022) for using a prohibited substance (Letrozole).
Kasait who qualified last year for the Olympics for the first time in her career after stunning the Rio 2016 silver medalist Hellen Obiri to win the 5,000m race at Kenya’s trials has agreed to be sanctioned for the Anti-Doping Rules (ADRVs) with a period of Ineligibility.
“The AIU, the Athlete and WADA (the Parties”) subsequently entered into a Case Resolution Agreement in accordance with Rule 10.8.2 ADR pursuant to which: the Athlete acknowledges that she committed ADRVs under Rule 2.1 and 2.2 of the ADR” part of the AIU statement read
Kasait who was then in Standard seven became the centre of global attention when she won first gold for Kenya in 3,000metres at the World Youth Championships in Ukraine in 2013
Athletics Kenya (AK) alongside the Anti-Doping Agency of Kenya (ADAK) have been intensifying their fight against doping through conducting an anti-doping seminar for all competing athletes in a bid to eradicate the menace.
Kenya remains in category “A” of the World Athletics and World Anti-Doping Agency watch list with over 28 middle and long distance runners having been banned for doping offences since 2017.
The event organised by AK alongside the Anti-Doping Agency of Kenya (ADAK) was aimed at educating athletes against doping even as the menace continues to in the country.
The government established Anti-Doping Agency of Kenya (ADAK) through the Anti-Doping Act, 2016 with its mandate being to protect athletes’ fundamental rights to participate in doping-free sport
Letrozole is a Prohibited Substance under the World Anti-Doping Agency (“WADA”) 2022 Prohibited List under the category S4. Hormone and Metabolic Modulators.